Bryan Mcmichael
Förmögenhet: 161 821 $ per 2026-09-30
Förmögenhet: 161 821 $ per 2026-09-30
Bryan Mcmichael is Chief Financial Officer at Coherus Oncology, Inc. since 2024.
Mr. Mcmichael was Executive Director at Gilead Sciences, Inc. from 2016 to 2021.
Mr. Mcmichael completed undergraduate studies at San Diego State University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
COHERUS ONCOLOGY, INC. 0,09 % | 2026-05-29 | 133 736 ( 0,09 % ) | 161 821 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| COHERUS ONCOLOGY, INC. | Finansdirektör/CFO | 2023-12-08 |
| Företag | Position | Slut |
|---|---|---|
| GILEAD SCIENCES, INC. | Direktör/Styrelseledamot | 2021-03-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 3 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
San Diego State University
San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Coherus BioSciences, Inc.
Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån